Two years is too long – Understanding Canada’s Drug Access Pathway

Canadians wait two years for access to new medicines through our public drug plans. That’s a full year longer than patients in most other peer countries. Two years can feel like a lifetime for a patient waiting for access to life-saving medicines or treatments.


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.